CAAS Capital Management’s Amgen AMGN Stock Holding History

CAAS Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,200	Closed	-$1.62M	–	431
2024 Q2	$1.62M	Buy	+5,200	New	+$1.53M	0.52%	52
2024 Q1	–	Sell	-12,100	Closed	-$3.49M	–	517
2023 Q4	$3.49M	Buy	+12,100	New	+$3.3M	0.37%	70
2021 Q2	–	Sell	-7,500	Closed	-$1.87M	–	1029
2021 Q1	$1.87M	Buy	+7,500	New	+$1.79M	0.02%	616
2020 Q4	–	Sell	-12,200	Closed	-$3.1M	–	827
2020 Q3	$3.1M	Buy	+12,200	New	+$3.02M	0.07%	208

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CAAS Capital Management's AMGN Position: Q2 2021 in Review

CAAS Capital Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 4,050 shares — an estimated $1.01M sold.

CAAS Capital Management first reported a position in AMGN in Q3 2020 and held it in 2 quarters. The position peaked at $1.02M in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

CAAS Capital Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
CAAS Capital Management sold 4,050 Amgen shares in Q2 2021, an estimated $1.01M.
CAAS Capital Management first reported a position in Amgen in Q3 2020 and held it in 2 quarters.
CAAS Capital Management's Amgen position peaked at $1.02M in Q3 2020.
2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.